Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT05009082

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Led by AGO Study Group · Updated on 2025-09-10

970

Participants Needed

65

Research Sites

480 weeks

Total Duration

On this page

Sponsors

A

AGO Study Group

Lead Sponsor

E

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is an international, multicenter, randomized, open, Phase III trial to evaluate the efficacy and safety of carboplatin/paclitaxel/bevacizumab followed by bevacizumab and niraparib compared to carboplatin/paclitaxel followed by niraparib in patients with newly diagnosed advanced ovarian cancer.

CONDITIONS

Official Title

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients aged 18 years or older
  • Histologically confirmed advanced high grade non-mucinous, non-clear cell epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer FIGO stage III/IV (except IIIA2 without nodal involvement)
  • Upfront primary debulking surgery completed or plan to undergo chemotherapy with interval debulking surgery
  • Availability of tumor samples for BRCA testing before randomization
  • Ability to start systemic therapy within 8 weeks after cytoreductive surgery
  • ECOG performance status of 0 or 1
  • Estimated life expectancy longer than 3 months
  • Adequate bone marrow function (ANC ≥ 1.5 x 10^9/L, platelets ≥ 100 x 10^9/L, hemoglobin ≥ 9 g/dL)
  • Adequate coagulation parameters with stable or therapeutic INR/aPTT levels
  • Adequate liver and kidney function within defined lab limits
  • Normal or controlled blood pressure (≤140/90 mmHg)
  • Negative pregnancy test for women of childbearing potential within 7 days prior to treatment
  • Agreement to use effective contraception or abstinence during and for 6 months after treatment
  • Willingness and ability to comply with study visits, treatment, tests, and questionnaires
Not Eligible

You will not qualify if you...

  • Non-epithelial ovarian tumors
  • Low malignant potential or low grade ovarian tumors
  • Planned intraperitoneal chemotherapy
  • Other malignancies within 5 years except low-risk cancers with curative treatment
  • Prior systemic treatment for ovarian cancer
  • Previous PARP inhibitor treatment
  • Concurrent chemotherapy, anticancer therapy, or radiotherapy during study treatment
  • Prior participation or randomization in this trial
  • Major surgery within 1 week before treatment or incomplete recovery from surgery
  • Brain metastases or spinal cord compression
  • Significant recent traumatic injury
  • Recent cerebrovascular events (CVA, TIA, SAH) within 6 months
  • Recent thrombotic or hemorrhagic disorders within 3 months
  • Untreated or uncontrolled CNS diseases
  • Pregnant or breastfeeding women
  • Participation in another investigational drug trial recently
  • Known allergies to study drugs or their components
  • Non-healing wounds, active ulcers, or bone fractures
  • Significant cardiovascular diseases including recent heart attack or heart failure
  • Pre-existing neuropathy Grade 2 or higher
  • History of nephrotic syndrome
  • Persistent bowel obstruction
  • Recent serious gastrointestinal complications
  • Inability to swallow oral medication or gastrointestinal conditions affecting absorption
  • Other serious diseases or conditions posing high risk during treatment
  • History or current myelodysplastic syndrome or acute myeloid leukemia
  • Previous bone marrow or solid organ transplant
  • Recent use of high-dose aspirin or platelet aggregation inhibitors
  • Poor medical risk due to serious uncontrolled diseases or infections
  • Known active hepatitis B or C
  • History of Posterior Reversible Encephalopathy Syndrome (PRES)
  • Chronic inflammatory bowel disease under active treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 65 locations

1

Klinikum St. Marien Amberg

Amberg, Germany

Actively Recruiting

2

Klinikum Augsburg

Augsburg, Germany

Actively Recruiting

3

Hochtaunus-Kliniken

Bad Homburg, Germany

Actively Recruiting

4

Helios Klinikum Berlin-Buch

Berlin, Germany

Actively Recruiting

5

Onkologische Schwerpunktpraxis Bielefeld

Bielefeld, Germany

Actively Recruiting

6

Städt. Klinikum Brandenburg

Brandenburg an der Havel, Germany

Actively Recruiting

7

Klinikum Bremen Mitte

Bremen, Germany

Actively Recruiting

8

Klinikum Chemnitz

Chemnitz, Germany

Actively Recruiting

9

St. Elisabeth-Krankenhaus Köln-Hohenlind

Cologne, Germany

Actively Recruiting

10

Klinikum Dortmund

Dortmund, Germany

Actively Recruiting

11

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, Germany

Actively Recruiting

12

Florence-Nightingale-Krankenhaus Düsseldorf

Düsseldorf, Germany

Not Yet Recruiting

13

Universitätsfrauenklinik Düsseldorf

Düsseldorf, Germany

Actively Recruiting

14

KEM Essen | Evang. Kliniken Essen-Mitte gGmbH

Essen, Germany

Actively Recruiting

15

Universitätsklinikum Essen

Essen, Germany

Actively Recruiting

16

Klinikum Esslingen GmbH

Esslingen am Neckar, Germany

Actively Recruiting

17

Universitätsklinikum Frankfurt

Frankfurt, Germany

Actively Recruiting

18

Klinikum Frankfurt Höchst

Frankfurt am Main, Germany

Actively Recruiting

19

Universitätsklinikum Gießen

Giessen, Germany

Actively Recruiting

20

Klinikum Gütersloh

Gütersloh, Germany

Actively Recruiting

21

Universitätsklinikum Halle

Halle, Germany

Actively Recruiting

22

Albertinen Krankenhaus

Hamburg, Germany

Actively Recruiting

23

Mammazentrum HH am Krankenhaus Jerusalem

Hamburg, Germany

Actively Recruiting

24

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Actively Recruiting

25

Gynäkologisch-Onkologische Praxis am Pelikanplatz

Hanover, Germany

Actively Recruiting

26

Universitätsklnikum Heidelberg

Heidelberg, Germany

Actively Recruiting

27

Klinikum am Gesundbrunnen / SLK-Kliniken Heilbronn GmbH

Heilbronn, Germany

Actively Recruiting

28

Gyn.-onkolog. Gemeinschaftspraxis Hildesheim

Hildesheim, Germany

Actively Recruiting

29

Universtitätsklinikum Jena

Jena, Germany

Actively Recruiting

30

Städtisches Klinikum Karlsruhe

Karlsruhe, Germany

Actively Recruiting

31

ViDia Christliche Kliniken Karlsruhe

Karlsruhe, Germany

Actively Recruiting

32

Klinikum Kassel

Kassel, Germany

Actively Recruiting

33

Klinikverbund Kempten-Oberallgäu gGmbH

Kempten, Germany

Not Yet Recruiting

34

Klinikum Konstanz

Konstanz, Germany

Not Yet Recruiting

35

Zentrum für ambulante gynäkologische Onkologie am HELIOS Klinikum Krefeld

Krefeld, Germany

Actively Recruiting

36

Universitätsklinikum Leipzig

Leipzig, Germany

Actively Recruiting

37

St. Vincenz Krankenhaus

Limburg, Germany

Actively Recruiting

38

Klinikum Ludwigsburg

Ludwigsburg, Germany

Actively Recruiting

39

UKSH Campus Lübeck

Lübeck, Germany

Actively Recruiting

40

Universitätsmedizin Mainz

Mainz, Germany

Actively Recruiting

41

Universitätsklinikum Mannheim GmbH

Mannheim, Germany

Actively Recruiting

42

UKGM Gießen/Marburg Standort Marburg

Marburg, Germany

Actively Recruiting

43

Mühlenkreiskliniken, Johannes Wesling Klinikum Minden

Minden, Germany

Actively Recruiting

44

LMU Klinikum München-Großhadern

München, Germany

Actively Recruiting

45

Rotkreuzklinikum München

München, Germany

Actively Recruiting

46

Universitätsklinikum Münster

Münster, Germany

Actively Recruiting

47

Klinikum Neumarkt

Neumarkt, Germany

Actively Recruiting

48

MVZ Nordhausen

Nordhausen, Germany

Actively Recruiting

49

Ortenau Klinikum Offenburg-Kehl

Offenburg, Germany

Actively Recruiting

50

St. Vincenz Krankenhaus GmbH

Paderborn, Germany

Actively Recruiting

51

Studienzentrum Onkologie Ravensburg

Ravensburg, Germany

Actively Recruiting

52

Krankenhaus Barmherzige Brüder

Regensburg, Germany

Actively Recruiting

53

Klinikum am Steinenberg

Reutlingen, Germany

Actively Recruiting

54

RoMed Klinikum Rosenheim

Rosenheim, Germany

Actively Recruiting

55

Klinikum Südstadt Rostock

Rostock, Germany

Actively Recruiting

56

Thüringen-Kliniken "Georgius Agricola"

Saalfeld, Germany

Actively Recruiting

57

Leopoldina Krankenhaus Schweinfurt

Schweinfurt, Germany

Actively Recruiting

58

g.SUND

Stralsund, Germany

Actively Recruiting

59

Klinikum Stuttgart

Stuttgart, Germany

Actively Recruiting

60

Klinikum Traunstein

Traunstein, Germany

Actively Recruiting

61

Klinikum Mutterhaus

Trier, Germany

Actively Recruiting

62

Universitätsklinikum Tübingen

Tübingen, Germany

Actively Recruiting

63

Universitätsklinik Ulm

Ulm, Germany

Actively Recruiting

64

St. Josefs-Hospital

Wiesbaden, Germany

Actively Recruiting

65

Klinikum Worms

Worms, Germany

Actively Recruiting

Loading map...

Research Team

S

Sandra Polleis

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here